Phase III Randomized AUGMENT Study of Lenalidomide/Rituximab vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
BRITISH JOURNAL OF HAEMATOLOGY(2019)
关键词
follicular lymphoma,indolent lymphoma,lenalidomide,marginal zone lymphoma,NHL,rituximab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要